149 related articles for article (PubMed ID: 38630146)
1. Fragile hands: targeting nonmelanoma skin cancer on older hands using 595 nm pulsed dye laser.
Herron ED; Snyder AM; Hull CM; LoBello S; Herron MD
Lasers Med Sci; 2024 Apr; 39(1):101. PubMed ID: 38630146
[TBL] [Abstract][Full Text] [Related]
2. Single treatment of non-melanoma skin cancers using a pulsed-dye laser with stacked pulses.
Tran HT; Lee RA; Oganesyan G; Jiang SB
Lasers Surg Med; 2012 Aug; 44(6):459-67. PubMed ID: 22511036
[TBL] [Abstract][Full Text] [Related]
3. The effect of 595 nm pulsed dye laser on superficial and nodular basal cell carcinomas.
Shah SM; Konnikov N; Duncan LM; Tannous ZS
Lasers Surg Med; 2009 Aug; 41(6):417-22. PubMed ID: 19588534
[TBL] [Abstract][Full Text] [Related]
4. Single treatment of low-risk basal cell carcinomas with pulsed dye laser-mediated photodynamic therapy (PDL-PDT) compared with photodynamic therapy (PDT): A controlled, investigator-blinded, intra-individual prospective study.
Čarija A; Puizina-Ivić N; Vuković D; Mirić Kovačević L; Čapkun V
Photodiagnosis Photodyn Ther; 2016 Dec; 16():60-65. PubMed ID: 27516420
[TBL] [Abstract][Full Text] [Related]
5. Combined 585 nm pulsed-dye and 1,064 nm Nd:YAG lasers for the treatment of basal cell carcinoma.
Jalian HR; Avram MM; Stankiewicz KJ; Shofner JD; Tannous Z
Lasers Surg Med; 2014 Jan; 46(1):1-7. PubMed ID: 24272664
[TBL] [Abstract][Full Text] [Related]
6. Multiple basal cell carcinomas in Gorlin Syndrome treated with pulsed dye laser.
Marous M; Mueller K; Tausk F
J Cosmet Laser Ther; 2020 Nov; 22(6-8):230-231. PubMed ID: 33849368
[TBL] [Abstract][Full Text] [Related]
7. Optimal cosmetic outcomes for basal cell carcinoma: a retrospective study of nonablative laser management.
Markowitz O; Tongdee E; Levine A
Cutis; 2019 May; 103(5):292-297;E1;E2;E3. PubMed ID: 31233573
[TBL] [Abstract][Full Text] [Related]
8. The pulsed dye laser for the treatment of basal cell carcinoma.
Ballard CJ; Rivas MP; McLeod MP; Choudhary S; Elgart GW; Nouri K
Lasers Med Sci; 2011 Sep; 26(5):641-4. PubMed ID: 21748324
[TBL] [Abstract][Full Text] [Related]
9. The effect of pulsed dye laser on high-risk basal cell carcinomas with response control by Mohs micrographic surgery.
Alonso-Castro L; Ríos-Buceta L; Boixeda P; Paoli J; Moreno C; Jaén P
Lasers Med Sci; 2015 Sep; 30(7):2009-14. PubMed ID: 25359622
[TBL] [Abstract][Full Text] [Related]
10. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
Marcil I; Stern RS
Arch Dermatol; 2000 Dec; 136(12):1524-30. PubMed ID: 11115165
[TBL] [Abstract][Full Text] [Related]
11. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
12. Pulsed dye laser in the treatment of basal cell carcinoma: A single session versus two sessions - a randomized controlled trial.
Abd El-Naby NM; El-Far NN; Al-Shenawy HA; Elshwadfy SE; Koura AA
Indian J Dermatol Venereol Leprol; 2019; 85(5):475-480. PubMed ID: 31062722
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a 595-nm Pulsed Dye Laser for the Treatment of Basal Cell Carcinoma Using One Double-Stacked Pulse Session: A Randomized, Double-Blinded Controlled Trial.
Chow M; Eimpunth S; Hamman MS; Jiang SIB
Dermatol Surg; 2021 May; 47(5):630-633. PubMed ID: 32852428
[TBL] [Abstract][Full Text] [Related]
14. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
Karagas MR; McDonald JA; Greenberg ER; Stukel TA; Weiss JE; Baron JA; Stevens MM
J Natl Cancer Inst; 1996 Dec; 88(24):1848-53. PubMed ID: 8961975
[TBL] [Abstract][Full Text] [Related]
15. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer.
Marmur ES; Schmults CD; Goldberg DJ
Dermatol Surg; 2004 Feb; 30(2 Pt 2):264-71. PubMed ID: 14871220
[TBL] [Abstract][Full Text] [Related]
16. The role of the 595-nm pulsed dye laser in treating superficial basal cell carcinoma: outcome of a double-blind randomized placebo-controlled trial.
Karsai S; Friedl H; Buhck H; Jünger M; Podda M
Br J Dermatol; 2015 Mar; 172(3):677-83. PubMed ID: 25040296
[TBL] [Abstract][Full Text] [Related]
17. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
18. Demographic and tumor characteristics of patients diagnosed with nonmelanoma skin cancer: 13-year retrospective study.
Mistry N; Abanto Z; Bajdik C; Rivers JK
J Cutan Med Surg; 2012; 16(1):32-8. PubMed ID: 22417993
[TBL] [Abstract][Full Text] [Related]
19. The effect of hydrochlorothiazide on the recurrence of nonmelanoma skin cancer: a 7-year retrospective study comprising 300 patients.
Özkan B; Savran S; Akıncı K; Albayati A; Uysal Pİ; Uysal AÇ
Turk J Med Sci; 2023 Jun; 53(3):760-752. PubMed ID: 37476909
[TBL] [Abstract][Full Text] [Related]
20. Raman spectroscopy differentiates squamous cell carcinoma (SCC) from normal skin following treatment with a high-powered CO2 laser.
Fox SA; Shanblatt AA; Beckman H; Strasswimmer J; Terentis AC
Lasers Surg Med; 2014 Dec; 46(10):757-72. PubMed ID: 25345858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
